THE DEAL, AT A GLANCE
From the announcementGenmedicn
01Who is involvedBacked by Novo Holdings A/S, Catalio Capital Management, SymBiosis, newFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedGenmedicn raised Series A, announced 2026-10-07From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersGenmedicn's $0M Series A extension is a disclosed financing event in Unclassified, where 974 other trailing 30-day rounds totaled $655417M, positioning the round as a…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Genmedicn · Financing Record
Explore source-linked visual explanations for Genmedicn. Unsupported claims are withheld while source review continues.
Record 13580 · Recorded date: 2026-10-07
Explore company records →